General information

Announcements(0)

Greetings from the Chair

Overview

Web abstract

Registration

Information for Speakers, Presenters and Chairs

Program

Sessions

Search presentations

General information 2

Abstract Submission (Oral/Poster Presentation)

pharm143_en.png

icon_20251203182619268.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

<br>Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Download PDF for print

Timetable

Development of integrated database for experiments and simulations

In recent years, organic compounds with a molecular weight of about 500 to 2000, so-called middle molecules, are expected as one of promising drug discovery modalities. In particular, there are great expectations for its usefulness in the creation of pharmaceuticals based on the control of signal transduction, originating from intracellular protein-protein interactions. However, to accelerate middle molecule drug discovery, it is necessary to understand and overcome problems specific to middle molecules. In particular, the low solubility and low membrane permeability of middle molecules are associated with the characteristics of high-molecular compounds such as antibodies. What kind of approach would be effective? There are various chemotypes such as alkaloids, peptides, and oligonucleic acids, even though they are middle molecules. We thought it important to "collect, synthesize, analyze based on a unified method, organize and integrate the results, share and utilize information" of various chemotype medium molecules. Therefore, we developed multifaceted middle molecule research by a heterogeneous group of researchers with different specialties. In this symposium, we will report on these results.

Challenges facing middle molecule drug discovery and how to overcome them

The 143rd Annual Meeting of the Pharmaceutical Society of Japan (Sapporo)

Presentation Information

[S15-04]Development of integrated database for experiments and simulations

Password required to view